Prelude Capital Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Prelude Capital Management’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-94,075	Closed	-$1.64M	–	1600
2024 Q4	$1.64M	Buy	+94,075	New	+$1.27M	0.1%	226
2023 Q4	–	Sell	-17,649	Closed	-$143K	–	1420
2023 Q3	$143K	Buy	+17,649	New	+$144K	0.01%	957
2023 Q2	–	Sell	-14,649	Closed	-$117K	–	1390
2023 Q1	$117K	Buy	+14,649	New	+$151K	0.01%	936
2020 Q4	–	Sell	-20,000	Closed	-$254K	–	2110
2020 Q3	$254K	Buy	+20,000	New	+$251K	0.01%	613

Other funds holding PTVE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prelude Capital Management's PTVE Position: Q1 2025 in Review

Prelude Capital Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q1 2025, closing a stake of 94,075 shares — an estimated $1.64M sold.

Prelude Capital Management first reported a position in PTVE in Q3 2020 and held it in 4 quarters. The position peaked at $1.64M in Q4 2024. 163 funds tracked by Wall St. Rank hold PTVE as of Q1 2025.

Prelude Capital Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q1 2025 after selling out during the quarter.
Prelude Capital Management sold 94,075 Pactiv Evergreen Inc. Common stock shares in Q1 2025, an estimated $1.64M.
Prelude Capital Management first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 4 quarters.
Prelude Capital Management's Pactiv Evergreen Inc. Common stock position peaked at $1.64M in Q4 2024.
163 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q1 2025.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.